Tellgen Corp (300642) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.024x

Based on the latest financial reports, Tellgen Corp (300642) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥36.19 Million ≈ $5.30 Million USD) by net assets (CN¥1.53 Billion ≈ $223.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300642 equity to assets ratio to measure how much of total assets are equity-financed.

Tellgen Corp - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Tellgen Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Tellgen Corp earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Tellgen Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tellgen Corp ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Yangzhou Chenhua New Material Co Ltd
SHE:300610
-0.012x
Prataap Snacks Limited
NSE:DIAMONDYD
0.038x
Yeo Teknoloji Enerji ve Endustri AS
IS:YEOTK
-0.363x
Aeluma, Inc
NASDAQ:ALMU
-0.006x
Envipco Holding N.V.
AS:ENVI
0.047x
Guangxi Hechi Chemical Co Ltd
SHE:000953
0.071x
Harbin VITI Electronics Corp
SHG:603023
-0.020x
Imagicaaworld Entertainment Limited
NSE:IMAGICAA
0.045x

Annual Cash Flow Conversion Efficiency for Tellgen Corp (2012–2025)

The table below shows the annual cash flow conversion efficiency of Tellgen Corp from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Tellgen Corp market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.48 Billion
≈ $216.63 Million
CN¥143.23 Million
≈ $20.96 Million
0.097x -10.78%
2024-12-31 CN¥1.52 Billion
≈ $222.14 Million
CN¥164.62 Million
≈ $24.09 Million
0.108x +31.75%
2023-12-31 CN¥1.54 Billion
≈ $224.72 Million
CN¥126.40 Million
≈ $18.50 Million
0.082x -26.01%
2022-12-31 CN¥1.48 Billion
≈ $216.67 Million
CN¥164.72 Million
≈ $24.10 Million
0.111x +88.02%
2021-12-31 CN¥1.40 Billion
≈ $204.32 Million
CN¥82.61 Million
≈ $12.09 Million
0.059x -22.61%
2020-12-31 CN¥1.27 Billion
≈ $185.34 Million
CN¥96.83 Million
≈ $14.17 Million
0.076x -48.90%
2019-12-31 CN¥1.17 Billion
≈ $171.01 Million
CN¥174.84 Million
≈ $25.59 Million
0.150x -5.02%
2018-12-31 CN¥1.02 Billion
≈ $149.87 Million
CN¥161.32 Million
≈ $23.61 Million
0.158x +33.13%
2017-12-31 CN¥895.86 Million
≈ $131.09 Million
CN¥106.00 Million
≈ $15.51 Million
0.118x -65.30%
2016-12-31 CN¥288.65 Million
≈ $42.24 Million
CN¥98.42 Million
≈ $14.40 Million
0.341x +1.41%
2015-12-31 CN¥192.33 Million
≈ $28.14 Million
CN¥64.67 Million
≈ $9.46 Million
0.336x +7.97%
2014-12-31 CN¥131.05 Million
≈ $19.18 Million
CN¥40.81 Million
≈ $5.97 Million
0.311x +12.41%
2013-12-31 CN¥95.04 Million
≈ $13.91 Million
CN¥26.33 Million
≈ $3.85 Million
0.277x +193.02%
2012-12-31 CN¥72.47 Million
≈ $10.60 Million
CN¥6.85 Million
≈ $1.00 Million
0.095x --

About Tellgen Corp

SHE:300642 China Medical Devices
Market Cap
$300.62 Million
CN¥2.05 Billion CNY
Market Cap Rank
#14759 Global
#4359 in China
Share Price
CN¥12.66
Change (1 day)
+2.93%
52-Week Range
CN¥11.22 - CN¥31.30
All Time High
CN¥46.24
About

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in… Read more